CAPRICOR THERAPEUTICS, INC. (CAPR) Operating cash flow 2016–2025
CAPRICOR THERAPEUTICS, INC. (CAPR) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$69.8MFY2025 · since FY2016: -$14.5M → -$69.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$69.8M | -74.5% |
| FY2024 | -$40.0M | -56.3% |
| FY2023 | -$25.6M | -620.6% |
| FY2022 | $4.9M | +129.2% |
| FY2021 | -$16.8M | -67.2% |
| FY2020 | -$10.1M | -47.4% |
| FY2019 | -$6.8M | +50.8% |
| FY2018 | -$13.9M | +2.6% |
| FY2017 | -$14.2M | +1.5% |
| FY2016 | -$14.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CAPR financial trends
CAPR RevenueCAPR Net incomeCAPR Net marginCAPR Gross profitCAPR Gross marginCAPR Operating incomeCAPR Operating marginCAPR Free cash flowCAPR Capital expendituresCAPR Return on equityCAPR Stock buybacksCAPR Dividends paidCAPR Total assetsCAPR Total liabilitiesCAPR Shareholders’ equityCAPR overview →